Member Info for Rokerpark68

ROCKZ

Let's hope you're right.

@jh2704

Yes I think you are on the right lines.

@ROCKZ

Errrr....I think he might.

I've just been looking back at some of my posts about Accustem last year. This was from 22 September 2020. How disappointing. Come on GC, get us some real liquidity!

"Something that is getting under my skin just now is a concern I mentioned earlier today, that I dislike the fact that the demerger is not conditional on the admission of the Accustem shares ie. the circular clearly points to a gap between demerger on 30 October and admission (listing) of the Accustem shares. So for a while (up to two months in the circular) we could have no liquidity in our Accustem shares. Moreover there is no obligation on the board to ever do the listing, although I have to believe it intends to. But is there a circumstance where admission might never happen and we get stuck with unlisted, illiquid stock in Accustem?"

@jh2704

So do I.

Reading the circular dated 15 July this looks like a really important acquisition which takes SRC into a different league.

Nordkalk is clearly a quality business with good performance metrics which make the acquisition price look reasonable enough. It is also going to be immediately significantly earnings enhancing.

If the share price drifts down at all in the short term given the amount of new stock I will add again. I bought at 54p and 70p, then sold a few at 93p a short time ago to trim the position, but this deal looks like a step-change for the company.

I guess so, yes.

@casa

I have just had a long chat with HL about my Accustem shares.

Basically, if the company does, in the first instance, list on an OTC market in the US, HL won't be able to trade them for me, which I pretty much knew already. Their platform doesn't cover OTC markets. If I want liquidity my only option will be to transfer them out of the various HL accounts I hold them in to a platform that does trade OTC stocks. They won't charge for the transfers.

Not good, but not a surprise.

It's going to take some time before we understand how UK holders of Accustem stock are actually going to get liquidity. Listing on any major exchange was always unlikely given the company has no financial track record etc etc. We will just have to see how an US OTC listing eventually links into the larger UK dealing platforms.

I think (know) the situation with Accustem has polluted institutional/professional attitudes to TILS since the end of last year. We need larger investors to really take an interest in TILS again to drive the share price . The low volumes, shorting activity and the bizarre dislocation between the US and UK shares have all contributed to a steady downward spiral, especially as short-term TILS newsflow has been at best patchy.

It will therefore be great to get Accustem out of the way, hopefully with a good valuation which will help improve market sentiment towards the TILS board's ability to deliver. Then we need some really strong pipeline newsflow to get a new cohort of larger investors excited. It can happen.

Jack
Accustem is a crap shoot in my mind - I have no idea what it is going to be worth. Just hoping for the best if it is still performing well as a product.

Sporty66
I could never really fully stop believing in Sunderland, but it's the hope that kills you, interspersed with long gruelling periods of despair. But I will be heading up to the SoL at some point again soon, like a moth to a lamp.

Yes - totally agree.

This will make you smile - I paid £150 for a half-season ticket in the New Year and went to the Carlisle home which was abandoned after 10 minutes due to a frozen pitch. Then the January lockdown happened and I didn't get to see any more live home games. Expensive 10 minutes.... although Harrogate did score a cracking goal.

Happily, all the home games were streamed for free for season ticket holders after lockdown though.

I despair of Sunderland now.

Just about to buy a Harrogate Town season ticket.

@LeddachJack

Pleased for you Jack - that's been an uncomfortable wait for you.
Let's hope they attract a really good valuation.

Cheers

@lovelyboy

Yes, I saw that my Accustem lines at HL had gone from "entitlement" to "ORDGBP.01" this morning. At least this means we have moved from a preliminary allocation to an actual holding in Accustem stock, albeit unlisted and illiquid at this point pending IPO. It also means if the Accustem was sold tomorrow we will be holding shares that we could actually sell in a private sale.

@Howzaty

I have been a holder since March 2020. This is my first post on this board although I read it daily, largely for its entertainment value and amusing personal vendettas. Makes me chuckle every day.

I totally agree with you that the real value here will be in the Affirmer technology. I see the LFT opportunity as primarily a source of funding over the next couple of years. The CEO has, however, over-promised on LFT timelines several times - there is no disguising that - and as we all know the market responds very negatively to missed self-imposed deadlines. Overall, however, for me this doesn't detract from the longer-term Affirmer opportunity.

Yes it's frustrating that the share price is so volatile, but unless you are a trader and you like the volatility you just have to take it in your stride and stay focused on fundamentals, which I continue to believe are very attractive.

Yes, I received mine in my HL account on 11 June.

Hi there MIKODX,

I was just being tongue-in-cheek about being told off - I do appreciate Accustem must be a side show for investors who have invested since the demerger, so I see your viewpoint as well.

ATB

RP68

Let's hope this generates some renewed enthusiasm in the US as well. Sentiment has been pretty poor over there for a long time.